Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1
- PMID: 16382041
- DOI: 10.1196/annals.1339.018
Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1
Abstract
Recent developments in the generation and analysis of transgenic mouse models have improved our understanding of the early stages of prostate tumorigenesis. Analysis of models based on the homeodomain protein Nkx3.1 and the zinc finger protein Egr1 suggests that these transcription factors play distinct roles in the initiation and progression of precursor prostatic intraepithelial neoplasia (PIN) lesions, respectively. Nkx3.1 is a candidate prostate tumor suppressor gene (TSG) that demonstrates haploinsufficiency. Disruption of one or both copies of the murine Nkx3.1 gene leads to the development of epithelial hyperplasia and PIN. This appears to be a consequence of delayed exit from the cell cycle by differentiating prostate luminal epithelial cells in Nkx3.1 mutant mice. Gene expression profiling has provided additional insight into the basis of haploinsufficiency in Nkx3.1 mutant mice. A reduction in Nkx3.1 dosage leads to dramatic alterations in the expression of a subset of genes by altering the probability of a _target gene existing in the "on" or "off" state. The immediate early gene Egr1, on the other hand, is overexpressed in human and mouse prostate tumors and PIN lesions and regulates the expression of several genes implicated in prostate tumor progression, including platelet-derived growth factor and insulin-like growth factor II. Prostate cancer-prone mice lacking Egr1 exhibit a significant delay in tumor progression. Specifically, Egr1 deficiency impairs the transition from PIN to invasive carcinoma. Thus, Nkx3.1 and Egr1 regulate gene programs involved in distinct aspects of prostate tumorigenesis.
Similar articles
-
Impaired prostate tumorigenesis in Egr1-deficient mice.Nat Med. 2001 Jan;7(1):101-7. doi: 10.1038/83231. Nat Med. 2001. PMID: 11135623
-
Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis.Cancer Res. 2002 Jun 1;62(11):2999-3004. Cancer Res. 2002. PMID: 12036903
-
Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer.Cancer Res. 2005 Feb 15;65(4):1164-73. doi: 10.1158/0008-5472.CAN-04-2688. Cancer Res. 2005. PMID: 15734999
-
Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis.Dev Dyn. 2003 Dec;228(4):767-78. doi: 10.1002/dvdy.10397. Dev Dyn. 2003. PMID: 14648854 Review.
-
Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis.J Cell Biochem. 2005 Feb 1;94(2):279-97. doi: 10.1002/jcb.20339. J Cell Biochem. 2005. PMID: 15565647 Review.
Cited by
-
Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN.Mol Cancer. 2013 Jun 21;12:67. doi: 10.1186/1476-4598-12-67. Mol Cancer. 2013. PMID: 23786676 Free PMC article.
-
NKX3.1 as a marker of prostatic origin in metastatic tumors.Am J Surg Pathol. 2010 Aug;34(8):1097-105. doi: 10.1097/PAS.0b013e3181e6cbf3. Am J Surg Pathol. 2010. PMID: 20588175 Free PMC article.
-
Deletion of NKX3.1 via CRISPR/Cas9 Induces Prostatic Intraepithelial Neoplasia in C57BL/6 Mice.Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820964425. doi: 10.1177/1533033820964425. Technol Cancer Res Treat. 2020. PMID: 33094683 Free PMC article.
-
Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70.Am J Pathol. 2008 Jan;172(1):225-35. doi: 10.2353/ajpath.2008.070065. Epub 2007 Dec 21. Am J Pathol. 2008. PMID: 18156210 Free PMC article.
-
The role of noise and positive feedback in the onset of autosomal dominant diseases.BMC Syst Biol. 2010 Jun 29;4:93. doi: 10.1186/1752-0509-4-93. BMC Syst Biol. 2010. PMID: 20587063 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous